CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a cost-effective bioinformatics tool for analyzing mutations in multiple myeloma, a type of blood cancer. By identifying driver mutation signatures, the tool will assist in early diagnosis and monitoring of disease progression, potentially improving patient outcomes.
Multiple myeloma (MM) is the second most common haematological cancer which is symptomless until the later stages, with few treatment options and poor long-term prognoses.
Next-generation DNA sequencing (NGS) has been used to identify and characterise the process of clonal evolution and disease progression in asymptomatic MM, however, there remains no viable prognostic NGS method which can be used by clinicians to leverage different mutations to predict progression.
The scientific literature ind…
UNIVERSITA DEGLI STUDI DI MILANO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Cyprus, LIMASSOL
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
